Global Laparoscopic Power Morcellators Market to Surpass US$ 153.5 Million by 2028, Says Coherent Market Insights (CMI)


SEATTLE, Feb. 07, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global laparoscopic power morcellators market is estimated to be valued at US$ 102.1 million in 2021 and is expected to exhibit a CAGR of 5.3 % during the forecast period (2021-2028).

Key Trends and Analysis of the Global Laparoscopic Power Morcellators Market:

Key trends in the market include increasing prevalence of uterus fibroids, increasing product clearance by regulatory authorities, and inorganic activities such as partnership, collaborations, etc.

Increasing prevalence of endometriosis is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period. For instance, on March 31, 2021, World Health Organization (WHO) released fact sheet for prevalence of endometriosis which is a disease where tissue similar to the lining of the uterus grows outside the uterus, causing pain and/or infertility, where it is mentioned that endometriosis affects roughly 10%, around 190 million of reproductive age women and girls globally.

Market players are engaged in research and development activities for their product to receive approval from regulatory authorities. For instance, ARK surgical Ltd, a medical device company based in Israel, developed power morcellators called LapBox, which contains features like double-barrier-walled tissue containment system, constant volume and constant air pressure, different sizes of ports, operates in inflated abdomen. The device has successfully completed first in human study and the company is working towards the U.S. Food and Drug Administration (FDA) submission and launch of product in the year 2022.

Request Sample copy of this Report @

Key Market Takeaways:

Increasing prevalence of uterine cancer is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period. For instance, National Cancer institute released cancer stat facts which states that uterine cancer estimated cases in 2021 were 66,570 and number of deaths occurred due to uterine cancer were12940, which represents 3.5% of all new uterine cancer cases in the U.S.

Among regions, North America is expected to hold a dominant position in the global laparoscopic power morcellators market over the forecast period, owing to increasing prevalence of uterine cancer in the U.S. population. For instance, according to the American cancer society in 2021, new cases of uterine cancer were 66,570 and 12,940 women in the U.S. died due to uterine cancer.

Competitive Landscape:

Key players operating in the global laparoscopic power morcellators market include LiNA Medical, Blue Endo, Johnson and Johnson, Endomedium, Hangzhou Kangji Medical Instruments, WISAP Medical Technology, Nouvag, Zhejiang Geyi Medical Instrument, Karl Storz GmbH, Medtronic, Richard Wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation.

Buy-Now this Research Report @

Market segmentation:

  • Global Laparoscopic Power Morcellators Market, By Application:
    • Hysterectomy
    • Myomectomy
    • Others
  • Global Laparoscopic Power Morcellators Market, By End User:
    • Hospitals and clinics
    • Surgical Centers 
  • Global Laparoscopic Power Morcellators Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Product Type (Hand (Resectoscope, Linear Cutter, Insufflators, Curved Stapler, Endoscopic Trocars, Prostatic Retractor, Cryoablation Device, Others), Monitoring & Visualization (Cameras & Video Support, Endoscopic Trocars with Optical View), Powered (Electrosurgical Unit, Lasers)), By Application (Laparoscopy Robotics Surgery Brachytherapy Cryosurgery), and By Region (North America, Europe) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Minimally Invasive Surgery Market, By Device Type (Surgical Devices (Ablation Devices, Electrosurgical Devices, Medical Robotic Systems), Monitoring & Visualization Devices, Endoscopy Devices), By Surgery (Orthopedic Surgery, Cosmetic Surgery, Breast Surgery, Vascular Surgery, Thoracic Surgery, Gynecological Surgery, Bariatric Surgery, Cardiac Surgery, Gastrointestinal Surgery, Urological Surgery), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedInTwitter


Contact Data